Offer - Urjas Oil for just ₹ 1 X
Zomelis D is an allopathic medicine The correct dosage of Zomelis D depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Zomelis D is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Zomelis D safe for pregnant women?
Zomelis D has many dangerous side effects in pregnant women. If you are pregnant, do not consume Zomelis D without medical advice.
Is the use of Zomelis D safe during breastfeeding?
Information about safety of Zomelis D for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Zomelis D on the Kidneys?
Zomelis D may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Zomelis D on the Liver?
There may be an adverse effect on the liver after taking Zomelis D. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Zomelis D on the Heart?
There is no research available on the side effects of Zomelis D on the heart. Therefore, its impact is unknown.
Zomelis D should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zomelis D unless your doctor advises you to do so -
Is this Zomelis D habit forming or addictive?
No, there is no any evidence that Zomelis D is addictive.
Interaction between Food and Zomelis D
There isn't any research available on the side effects of taking Zomelis D with food.
Interaction between Alcohol and Zomelis D
Taking alcohol with Zomelis D can be dangerous.
Zomelis D is not a known cause of alopecia (hair loss). However, the conditions treated by Zomelis D type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, you can take Zomelis D with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Zomelis D and long-term use can increase lactic acid and uric acid in the blood.
Yes, Zomelis D can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
Lactic acidosis associated with Zomelis D treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Zomelis D induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278